Cover Image

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma

Abstract Background Multiple studies have shown that tumor-associated macrophages (TAMs) promote cancer initiation and progression. However, the reprogramming of macrophages in the tumor microenvironment (TME) and the cross-talk between TAMs and malignant subclones in intrahepatic cholangiocarcinoma...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhao-Ru Dong (Author), Meng-Ya Zhang (Author), Ling-Xin Qu (Author), Jie Zou (Author), Yong-Heng Yang (Author), Yun-Long Ma (Author), Chun-Cheng Yang (Author), Xue-Lei Cao (Author), Li-Yuan Wang (Author), Xiao-Lu Zhang (Author), Tao Li (Author)
Format:	Book
Published:	BMC, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computational elucidation of spatial gene expression variation from spatially resolved transcriptomics data
by: Ke Li, et al.
Published: (2022)

Intrahepatic cholangiocarcinoma after the Fontan procedure
by: Yuichi Shibui, et al.
Published: (2019)

Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
by: Mina Komuta
Published: (2024)

Untargeted UPLC-MS-based metabolomics analysis reveals the metabolic profile of intrahepatic cholangiocarcinoma process and the intervention effect of Osthole in mice
by: Xin Chen, et al.
Published: (2022)

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
by: Sheng Hu, et al.
Published: (2022)

Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023)

Bulk and single‐cell spatial transcriptomic analysis reveals cuproptosis‐related molecular subtypes characterized by distinct tumour microenvironment infiltrates in colorectal cancer
by: Wenqin Luo, et al.
Published: (2023)

Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
by: Yang Z, et al.
Published: (2022)

Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis
by: Phoenix D. Bell, et al.
Published: (2020)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
by: Lulu Xie, et al.
Published: (2022)

Intrahepatic Cholangiocarcinoma Skin Metastasis in a Patient with Hidradenitis Suppurativa: A Rare Entity
by: Ali Y Fakhreddine, et al.
Published: (2020)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
by: He C, et al.
Published: (2021)

Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation
by: Ao Ren, et al.
Published: (2021)

Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
by: Yanxin Sun, et al.
Published: (2024)

Presentation of Intrahepatic Cholangiocarcinoma with Fulminant Hepatic Failure: A Case Report
by: Thara Pratap, et al.
Published: (2019)

Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta
by: Yu-bin He, et al.
Published: (2022)

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma
by: Pei Zhang, et al.
Published: (2024)

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis
by: Cindy Neuzillet, et al.
Published: (2022)

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration
by: Lavinia Patricia Mocan, et al.
Published: (2024)

Biocompatible Snowman-like Dimer Nanoparticles for Improved Cellular Uptake in Intrahepatic Cholangiocarcinoma
by: Ruyin Chen, et al.
Published: (2023)

Intrahepatic cholangiocarcinoma developing seven years after resection of congenital biliary dilatation
by: Kanako Omata, et al.
Published: (2020)

A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma
by: Zhenzhen Chu, et al.
Published: (2023)

Comprehensive Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Transcriptional Signatures of Macrophages in Intrahepatic Cholestasis of Pregnancy
by: Tang M, et al.
Published: (2024)

Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
by: Jing Bian, et al.
Published: (2022)

Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation-like Feature Associated with Bile Duct Adenoma
by: Ah-Young Kwon, et al.
Published: (2015)

HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2023)

Case report: Immunotherapy plus chemotherapy and stereotactic ablative radiotherapy (ICSABR): a novel treatment combination for Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma
by: Ruizhen Li, et al.
Published: (2023)

Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
by: Zhenyun Yang, et al.
Published: (2023)

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
by: Kang-shuai Li, et al.
Published: (2024)

Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging
by: Zhonghua Wang, et al.
Published: (2021)

Promise of spatially resolved omics for tumor research
by: Yanhe Zhou, et al.
Published: (2023)

Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link
by: Giovanni Brandi, et al.
Published: (2022)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
by: Yeh CN, et al.
Published: (2014)

Small duct type intrahepatic cholangiocarcinoma with extensive intraductal extension mimics an intraductal tubulopapillary neoplasm
by: Mark Fowler, et al.
Published: (2023)

Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2024)

Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma
by: Zheqi Liu, et al.
Published: (2024)

Transcriptomic Analysis Reveals a Link Between Hippo Signaling Pathway and Macrophages in Lungs of Mice with OVA-Induced Allergic Asthma
by: Xiao H, et al.
Published: (2022)

MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma
by: Hao Xu, et al.
Published: (2022)

Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation
by: Fei Song, et al.
Published: (2023)

Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomics
by: Dandan Song, et al.
Published: (2023)